GlaxoSmithKline Pharmaceuticals Limited
LIC's name is missing from the latest GlaxoSmithKline Pharmaceuticals Limited filing, indicating the investor either fully exited or trimmed its previous 1.08 percent stake below the 1 percent reporting threshold.
A leading pharmaceutical company, GlaxoSmithKline Pharmaceuticals researches, manufactures, and distributes a broad range of medicines and vaccines across India and internationally. The company operates across multiple therapeutic areas including respiratory, oncology, dermatology, and vaccines, serving healthcare providers and patients. Its integrated operations span drug development, manufacturing, quality assurance, and distribution networks throughout the country and beyond.
India's largest domestic institutional investor with over Rs 56 lakh crore in total AUM, of which roughly Rs 15 lakh crore sits in listed equities. Holds stakes in virtually every major listed Indian company. When LIC builds or exits a position, it moves markets. Government-owned and mandated to invest policyholder funds in Indian equities and bonds, making it the ultimate long-only, long-term India bull.